# Carboxyamidotriazole in Treating Patients With Stage III or Stage IV Non-small Cell Lung Cancer

> **NCT00003869** · PHASE3 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 186 (actual)

## Conditions studied

- Stage IIIA Non-small Cell Lung Cancer
- Stage IIIB Non-small Cell Lung Cancer
- Stage IV Non-small Cell Lung Cancer

## Interventions

- **DRUG:** carboxyamidotriazole
- **OTHER:** placebo
- **PROCEDURE:** quality-of-life assessment
- **OTHER:** laboratory biomarker analysis

## Key facts

- **NCT ID:** NCT00003869
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-04
- **Primary completion:** 2008-05
- **Final completion:** 2008-05
- **Target enrollment:** 186 (ACTUAL)
- **Last updated:** 2014-05-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003869

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003869, "Carboxyamidotriazole in Treating Patients With Stage III or Stage IV Non-small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00003869. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*